Related references
Note: Only part of the references are listed.Heat Shock Factor 1 Is a Substrate for p38 Mitogen-Activated Protein Kinases
Sharadha Dayalan Naidu et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
HSF1 Guardian of Proteostasis in Cancer
Chengkai Dai et al.
TRENDS IN CELL BIOLOGY (2016)
Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Protein kinase CK2 inhibition is associated with the destabilization of HIF-1α in human cancer cells
Barbara Guerra et al.
CANCER LETTERS (2015)
The kinase inhibitor D11 induces caspase-mediated cell death in cancer cells resistant to chemotherapeutic treatment
Barbara Guerra et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library
Barbara Guerra et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Protein kinase CK2 is required for the recruitment of 53BP1 to sites of DNA double-strand break induced by radiomimetic drugs
Barbara Guerra et al.
CANCER LETTERS (2014)
Comparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal Cancer Cells: Are There Common Determinants of Sensitivity?
Leticia Mayor-Lopez et al.
TRANSLATIONAL ONCOLOGY (2014)
A gain-of-function mutant p53-HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress
D. Li et al.
CELL DEATH & DISEASE (2014)
Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential
Amy S. Lee
NATURE REVIEWS CANCER (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Regulatory Coordination between Two Major Intracellular Homeostatic Systems HEAT SHOCK RESPONSE AND AUTOPHAGY
Karol Dokladny et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Protein kinase CK2 localizes to sites of DNA double-strand break regulating the cellular response to DNA damage
Birgitte B. Olsen et al.
BMC MOLECULAR BIOLOGY (2012)
Cell death by autophagy: facts and apparent artefacts
D. Denton et al.
CELL DEATH AND DIFFERENTIATION (2012)
mTOR Is Essential for the Proteotoxic Stress Response, HSF1 Activation and Heat Shock Protein Synthesis
Shiuh-Dih Chou et al.
PLOS ONE (2012)
Wild-type EGFR Is Stabilized by Direct Interaction with HSP90 in Cancer Cells and Tumors
Aarif Ahsan et al.
NEOPLASIA (2012)
ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy
Liang Qin et al.
AUTOPHAGY (2010)
CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
Adam Siddiqui-Jain et al.
CANCER RESEARCH (2010)
Regulation of DNA-dependent protein kinase by protein kinase CK2 in human glioblastoma cells
B. B. Olsen et al.
ONCOGENE (2010)
Targeting HSP90 for cancer therapy
D. Mahalingam et al.
BRITISH JOURNAL OF CANCER (2009)
Acquired Resistance to 17-Allylamino-17-Demethoxygeldanamycin (17-AAG, Tanespimycin) in Glioblastoma Cells
Nathatie Gaspar et al.
CANCER RESEARCH (2009)
CK2: A key player in cancer biology
J. H. Trembley et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
The Hsp90 mosaic: a picture emerges
Matthias P. Mayer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2
James S. Duncan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis
Marissa V. Powers et al.
CANCER CELL (2008)
Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin
Joanna L. Holmes et al.
CANCER RESEARCH (2008)
The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells
J. Li et al.
CELL DEATH AND DIFFERENTIATION (2008)
Protein kinase CK2 in human diseases
Barbara Guerra et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Targeting Hsp90: small-molecule inhibitors and their clinical development
Tony Taldone et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
OSU-03012 stimulates PKR-Like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cells
Margaret A. Park et al.
MOLECULAR PHARMACOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: A phase I Dose-Escalation study
Shanu Modi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Jayne M. Stommel et al.
SCIENCE (2007)
Abrogation of heat shock protein 70 induction as a strategy, to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.
F Guo et al.
CANCER RESEARCH (2005)
Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1:: Role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
WC Guo et al.
CANCER RESEARCH (2005)
Heat shock response modulators as therapeutic tools for diseases of protein conformation
SD Westerheide et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
CK2 binds, phosphorylates, and regulates its pivotal substrate Cdc37, an Hsp90-cochaperone
Y Miyata et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
DR Ciocca et al.
CELL STRESS & CHAPERONES (2005)
CD95-mediated alteration in Hsp70 levels is dependent on protein stabilization
CG Concannon et al.
CELL STRESS & CHAPERONES (2005)
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
A Kamal et al.
NATURE (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II
D Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
